MINGFA GROUP (00846) total contracted sales for the first three quarters were approximately RMB1.43 billion, a year-on-year decrease of approximately 25.9%.
MINGFA GROUP (00846) announced that, based on the Group's contracted sales records for the nine months ended September 30, 2026, the Group achieved total unaudited contracted sales of approximately RMB1.43 billion, a decrease of approximately 25.9% compared with approximately RMB1.93 billion for the same period in 2025.
MINGFA GROUP (00846) announced that, based on the Group's contracted sales records for the nine months ended September 30, 2026, the Group achieved total unaudited contracted sales of approximately RMB1.43 billion, a decrease of approximately 25.9% compared with approximately RMB1.93 billion for the same period in 2025.
Related Articles
.png)
DAWNRAYS PHARMA (02348) repurchased 216,000 shares on October 27 for HK$202,200.
YUM CHINA (09987) repurchased 23,700 shares on October 26 for HK$8.3516 million.
SIMCERE PHARMA (02096) repurchased 1.042 million shares on October 27 for approximately HK$10.751 million.
DAWNRAYS PHARMA (02348) repurchased 216,000 shares on October 27 for HK$202,200.
YUM CHINA (09987) repurchased 23,700 shares on October 26 for HK$8.3516 million.
SIMCERE PHARMA (02096) repurchased 1.042 million shares on October 27 for approximately HK$10.751 million.
